France-headquartered Groupe Novasep SAS provides manufacturing solutions for life sciences molecules and fine chemicals. Its US-based unit TangenX Technology Corporation produces single-use tangential flow filtration (“TFF”) cassettes and hardware used in downstream biopharmaceutical manufacturing processes.

For acquirer Repligen, a NASDAQ-listed life sciences company focused on bioprocessing technology, TangenX strengthened its position as a leader in single-use bioprocessing technologies and extended its reach into downstream processes, where disposables are increasingly being adopted by biopharmaceutical manufacturers.